Keywords
Cornea
Healing
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To describe the effects of topical insulin in the treatment of corneal pathologies. Literature review: Insulin is a protein hormone produced by the pancreatic beta cells, playing a crucial role in glycemic control and metabolic processes in the human body. Beyond these functions, insulin is essential for tissue repair, as it activates anti-inflammatory cytokines and promotes tissue healing. The cornea, a transparent, convex, avascular, and highly innervated ocular structure, acts as a protective barrier against injuries and infectious agents, playing a vital role in safeguarding the internal structures of the eye. In the treatment of corneal pathologies, topical insulin has proven effective in re-epithelializing persistent epithelial defects, reducing the need for surgical interventions. Therefore, topical insulin can enhance corneal recovery and minimize complications associated with traditional treatments. Final considerations: Topical insulin has proven effective in treating corneal pathologies, offering good availability, low cost, and excellent tolerance.
References
BHUIYAN ZA, et al. Localised insulin administration for wound healing in non-diabetic adults: A systematic review and meta-analysis of randomised controlled trials. Wound Repair and Regeneration: The International Journal of Tissue Repair and Regeneration, 2023; 31: 516-527.
CHEN S, et al. Insulin eye drops improve corneal wound healing in STZ-induced diabetic mice by regulating corneal inflammation and neuropeptide release. BMC Ophthalmology, 2024; 24(1): 1-10.
DANG DH, et al. Treatment of non-infectious corneal injury: Review of diagnostic agents, therapeutic medications, and future targets. Drugs, 2022; 82(2): 145-167.
DIAZ VD, et al. Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea. Acta Ophthalmologica, 2022; 100(4): 1-10.
DIAZ VD, et al. Topical insulin for refractory persistent corneal epithelial defects. European Journal of Ophthalmology, 2021; 31(5): 2280-2286.
FAI S, et al. Randomized controlled trial of topical insulin for healing corneal epithelial defects induced during vitreoretinal surgery in diabetics. Asia-Pacific Journal of Ophthalmology, 2017; 6(5): 418-424.
GUPTA Y, et al. Peripheral ulcerative keratitis. Survey of ophthalmology, 2021; 66(6): 977–998.
IKER ETCHEGARAY J, et al. Phagocytosis in the retina promotes local insulin production in the eye. Nature metabolism, 2023; 5: 207–218.
HASSANPOUR K, et al. Peripheral ulcerative keratitis: A review. Journal of Ophthalmic & Vision Research, 2022; 17: 252-275.
HOFFMAN JJ, et al. Management of filamentous fungal keratitis: A pragmatic approach. Journal of fungi (Basel, Switzerland), 2022; 8 (10): 1067.
HRYNYK M e NEUFELD RJ. Insulina e cicatrização de feridas. Burns: Journal of the International Society for Burn Injuries, 2014; 40(8): 1433-1446.
JAWORSKI M, et al. Topical insulin in neurotrophic keratopathy: A review of current understanding of the mechanism of action and therapeutic approach. Pharmaceutics, 2023; 16(1): 1-10.
LIN SR, et al. Recurrent corneal erosion syndrome. The British journal of ophthalmology, 2019; 103(9): 1204–1208.
MILLER DD, et al. Recurrent corneal erosion: A comprehensive review. Clinical Ophthalmology, 2019; 13: 325-335.
MOHAN RR, et al. Corneal stromal repair and regeneration. Progress in Retinal and Eye Research, 2022; 91: 101090.
NAPOLITANO, et al. Insulin resistance and skin diseases. The Scientific World Journal, 2015: 479354.
NANAVATY M. Treating corneal perforation related to neurotrophic keratitis. Acta ophthalmologica, 2024; 102: S279.
SRIDHAR MS, et al. Anatomy of cornea and ocular surface. Indian Journal of Ophthalmology, 2018; 66: 190.
STUARD WL,et al. O eixo IGF/insulina-IGFBP no desenvolvimento da córnea, cicatrização de feridas e doenças. Frontiers in Endocrinology, 2020; 11: 1-10.
VICARIO DLTM, et al. Topical insulin eye drops: Stability and safety of two compounded formulations for treating persistent corneal epithelial defects. Pharmaceutics, 2024; 16(5): 580.
VOSS K, et al. Non-infectious and non-hereditary diseases of the corneal epithelium. Experimental Eye Research, 2021; 202: 108316.
WANG AL, et al. Use of topical insulin to treat refractory neurotrophic corneal ulcers. Cornea, 2017; 36: 1426–1428.
WILSON SE, et al. Corneal wound healing. Experimental Eye Research, 2020; 197: 108089.
XIMENES KF, et al. The role of Descemet’s membrane in the pathogeny of corneal edema following anterior segment surgery. Revista brasileira de oftalmologia, 2014; 73: 262–268.
YANG P, et al. Aplicação tópica de insulina acelera a cicatrização de feridas diabéticas promovendo polarização anti-inflamatória de macrófagos. Journal of Cell Science, 2020; 133(19): 235838.